rs3093386
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_181078.3(IL21R):c.1450G>A(p.Gly484Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00558 in 1,613,504 control chromosomes in the GnomAD database, including 420 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_181078.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL21R | NM_181078.3 | c.1450G>A | p.Gly484Ser | missense_variant | 9/9 | ENST00000337929.8 | NP_851564.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL21R | ENST00000337929.8 | c.1450G>A | p.Gly484Ser | missense_variant | 9/9 | 1 | NM_181078.3 | ENSP00000338010.3 | ||
IL21R | ENST00000395754.4 | c.1450G>A | p.Gly484Ser | missense_variant | 9/9 | 1 | ENSP00000379103.4 | |||
IL21R | ENST00000564089.5 | c.1450G>A | p.Gly484Ser | missense_variant | 10/10 | 5 | ENSP00000456707.1 | |||
IL21R-AS1 | ENST00000563191.1 | n.1168C>T | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0306 AC: 4656AN: 152188Hom.: 225 Cov.: 33
GnomAD3 exomes AF: 0.00790 AC: 1975AN: 250086Hom.: 96 AF XY: 0.00571 AC XY: 774AN XY: 135524
GnomAD4 exome AF: 0.00297 AC: 4344AN: 1461198Hom.: 196 Cov.: 31 AF XY: 0.00248 AC XY: 1804AN XY: 726944
GnomAD4 genome AF: 0.0306 AC: 4660AN: 152306Hom.: 224 Cov.: 33 AF XY: 0.0294 AC XY: 2186AN XY: 74472
ClinVar
Submissions by phenotype
Cryptosporidiosis-chronic cholangitis-liver disease syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at